1. Home
  2. HOVR vs CUE Comparison

HOVR vs CUE Comparison

Compare HOVR & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$1.82

Market Cap

80.5M

Sector

Finance

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.28

Market Cap

27.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOVR
CUE
Founded
2013
2014
Country
Canada
United States
Employees
N/A
41
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.5M
27.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
HOVR
CUE
Price
$1.82
$0.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$10.33
$3.00
AVG Volume (30 Days)
454.6K
442.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.14
EPS
N/A
N/A
Revenue
N/A
$9,287,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
69.16
52 Week Low
$0.35
$0.23
52 Week High
$4.18
$1.05

Technical Indicators

Market Signals
Indicator
HOVR
CUE
Relative Strength Index (RSI) 45.15 39.65
Support Level $1.70 $0.27
Resistance Level $1.90 $0.36
Average True Range (ATR) 0.15 0.03
MACD -0.01 0.00
Stochastic Oscillator 27.14 14.60

Price Performance

Historical Comparison
HOVR
CUE

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: